Caterina Vicentini

ARC-Net Research Centre, University and hospital trust of Verona

Affiliated withUniversity and hospital trust of Verona

Research Area

Biography

Caterina Vicentini has not added Biography.
If you are Caterina Vicentini and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2019

Other Publications

Article	Year
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association\| PubMed ID: 24272205	2014
Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract. Molecules (Basel, Switzerland)\| PubMed ID: 24566314	2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups. Oncotarget\| PubMed ID: 24867389	2014
Reporting tumor molecular heterogeneity in histopathological diagnosis. PloS one\| PubMed ID: 25127237	2014
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies. Oncotarget\| PubMed ID: 26246487	2015
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes. BMC cancer\| PubMed ID: 26754001	2016
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5. Cancer cell\| PubMed ID: 27846390	2016
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 a... The Journal of pathology\| PubMed ID: 27873319	2017
Whole-genome landscape of pancreatic neuroendocrine tumours. Nature\| PubMed ID: 28199314	2017
Fhit down-regulation is an early event in pancreatic carcinogenesis. Virchows Archiv : an international journal of pathology\| PubMed ID: 28289900	2017
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma. Scientific reports\| PubMed ID: 29740198	2018
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance. Pathology, research and practice\| PubMed ID: 30190183	2018
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine. Virchows Archiv : an international journal of pathology\| PubMed ID: 30219970	2018
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas. The Journal of pathology\| PubMed ID: 30306561	2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 31085341	2019